Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Vioxx (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-8 of 8
» View wsbtradio.com items only
    Jun 14, 2013 |Story| Reuters
  1. EU regulator advises caution on painkiller diclofenac

    Reuters
    LONDON, June 14 (Reuters) - Europe's drugs agency warned on Friday that use of the common painkiller diclofenac, especially in high doses, carries extra heart attack risks which should be taken into consideration by doctors prescribing the drug. While it...

    Tags: Merck & Company Incorporated, Heart Disease, High Blood Pressure, Drugs and Medicines, Ibuprofen (drug)

  2. Jun 14, 2013 |Story| Reuters
  3. Agencia de medicamentos de la UE advierte sobre riesgos del diclofenac

    Reuters
    LONDRES, 14 jun (Reuters) - La Agencia Europea de Medicamentos advirtió el viernes que el uso del analgésico común diclofenac, especialmente en dosis elevadas, conlleva un riesgo adicional de ataques cardíacos que los médicos que recetan el fá...

    Tags: Merck & Company Incorporated, Diabetes

  4. Jun 14, 2013 |Story| Reuters
  5. REENVÍO-Agencia de medicamentos de la UE advierte sobre riesgos del diclofenaco

    Reuters
    (Reenvía colocando nombre más ampliamente difundido del fármaco en español) LONDRES, 14 jun (Reuters) - La Agencia Europea de Medicamentos advirtió el viernes que el uso del analgésico común diclofenaco, especialmente en dosis elevadas, conlleva...

    Tags: Merck & Company Incorporated, Diabetes

  6. May 30, 2013 |Story| Reuters
  7. High doses of common painkillers increase heart attack risks

    Reuters
    By Kate Kelland LONDON, May 30 (Reuters) - Long-term high-dose use of painkillers such as ibuprofen or diclofenac is "equally hazardous" in terms of heart attack risk as use of the drug Vioxx, which was withdrawn due to its potential dangers, researchers...

    Tags: Merck & Company Incorporated, Heart Disease, United Kingdom, Pain, Arthritis

  8. Mar 25, 2013 |Story| Los Angeles Times
  9. Girardi | Keese

    Given its deep bench of skilled trial attorneys—who include partner Amy Fisch Solomon —Girardi | Keese has pioneered litigation in the personal injury field, achieving more than $10 billion for its injured clients. “Amy is truly one of...

    Tags: Justice System, Lawyers, Trials, Avandia (drug), Actos (drug)

  10. Jan 5, 2012 |Story| Baltimore Sun
  11. Sun's position on medical marijuana is misguided and heartless

    The Sun's editorial on medical marijuana is misguided at best and heartless at worst ("Md. should go slow on medical marijuana," Jan. 3). It's clear that the reports of the medical marijuana work group were not reviewed carefully, and so the editorial...

    Tags: Medical Research, Health, Annapolis, Medical Marijuana Therapy, Baltimore County

  12. Jan 10, 2012 |Story| Los Angeles Times
  13. |Story
  14. Dec 18, 2004 |Story| Los Angeles Times
  15. FDA Warns of Celebrex Heart Risk

    Times Staff Writers
    WASHINGTON — The Food and Drug Administration on Friday warned physicians to consider alternatives to the popular arthritis drug Celebrex because of new evidence that, like the similar drug Vioxx, removed from the market in September, it doubles the...

    Tags: Merck & Company Incorporated, Rheumatoid Arthritis, Arthritis Foundation, Food and Drug Administration, General Practitioners

Original site for Vioxx (drug) topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Vioxx (drug) Photos
Shayna Cook has joined Goldman Ismail LLP as a partner...
(January 22, 2013)
Shayna Cook, partner, Goldman Ismail